Campaign: An awareness campaign for vaccination against the human papillomavirus (HPV), which causes cervical cancer (EN)
Ending date: now
The Human Papillomavirus (HPV) is one of the most common and easily transmitted viruses through sexual contact. It is estimated that 8 out of 10 women have been infected by the virus, which can either cause genital warts or lead to cancer, primarily in the cervix but also in various genital, anal, or oropharyngeal areas.
Experts explain that the virus is highly transmissible through sexual contact, even through genital skin-to-skin contact. For this reason, using condoms alone is not a sufficient means of protection against HPV.
According to many scientists, cervical cancer is currently the most frequent cancer in women aged 20-44, ranking as the second most common gynecological cancer in women after breast cancer. Moreover, it is the fourth most common cancer worldwide solely attributable to HPV.
Free distribution of the 9-valent vaccine for HPV, which provides protection against several (7 or more) potentially cancer-causing types of the virus (including types 16, 18, 31, 33, 45, 52, 58) and type 2 (6, 11) that cause the majority of genital warts.
A women’s movement to fight for a future generation of women where cervical cancer is no longer a threat.
Free vaccination for all girls aged 11 to 18 years old
With the message #vazoume_telos!, MSD introduced the new awareness campaign for vaccination against the Human Papillomavirus (HPV), which is associated with the development of cervical cancer and various forms of cancer. The campaign calls on women, especially mothers, to join forces by vaccinating girls from the age of 11, protecting them from HPV and collectively overcoming cervical cancer. Free for girls aged 11 to 18 years old, as well as individuals of both genders at high risk (immunosuppressed) aged 11-26 years, healthcare personnel, and men who have sexual relations with other men
Informing parents and young girls and boys
In Greece, more than 1,500,000 vaccines have been administered. The safety and effectiveness of the vaccine are supported by numerous research studies, and continuous assesments.